Clinical trial
Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents (EBECA)
NCT04461821 is registered in ClinicalTrials.gov with University Children's Hospital Basel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents (EBECA)
- Lead sponsor
- University Children's Hospital Basel
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 11, 2020
- Completion date
- July 31, 2030
- Enrollment
- 3,600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neurological disorders, respiratory diseases, type 1 diabetes